Sign in
4

Changes in Ownership

Kalaris Therapeutics, Inc. Filed Acc 0001209191-23-004500

Chief Accounting Officer sold 1,895 shares at an average $5.09 ($9,645)

From the SEC's structured data for this filing

Trades in this filing

Hagen Brett R · Chief Accounting Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-01-19 Sale : show line 1 in the form −1,557 $5.08 $7,906 74,342 D
2023-01-20 Sale : show line 2 in the form −338 $5.14 $1,739 74,004 D
Open-market sales · 1,895 sh · avg $5.09 · $9,645
Loading xslF345X03/doc4.xml…